Patents by Inventor Annette Larsen

Annette Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120157472
    Abstract: The present invention relates to a method of treating patients suffering from colorectal cancer characterized by coadministration of BIBF 1120 and BIBW 2992, wherein in said method BIBF 1120 is administered according to a continuous daily regimen and BIBW 2992 is administered according to a weekly alternating on-off regimen, pharmaceutical compositions and kits suitable for this method as well as their preparation.
    Type: Application
    Filed: January 13, 2010
    Publication date: June 21, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Annette Larsen, Anke Baum, Frank Hilberg, Flavio Solca
  • Publication number: 20110312922
    Abstract: The present invention relates to the discovery of a new protein complex in human biological materials that can be used for diagnostic and other purposes. The invention further relates to products, methods and uses related to said protein complex.
    Type: Application
    Filed: October 17, 2008
    Publication date: December 22, 2011
    Applicant: ERAC AS
    Inventors: Magne K. Fagerhol, Annette Larsen, Tor Magne Madland, Johan G. Brun
  • Publication number: 20080108598
    Abstract: The use of substituted amides for modulating the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11?HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
    Type: Application
    Filed: January 3, 2008
    Publication date: May 8, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Andersen, Gita Camilla Kampen, Inge Christensen, John Mogensen, Annette Larsen, John Kilburn
  • Publication number: 20070270408
    Abstract: The use of substituted pyrazolo[1,5-a]pyrimidines for modulating the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and the use of these compounds as pharmaceutical compositions are described. Also a novel class of substituted pyrazolo[1,5-a]pyrimidines their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described The present compounds are modulators and more specifically inhibitors of the activity of 11?HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
    Type: Application
    Filed: October 11, 2005
    Publication date: November 22, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Andersen, Gita Camilla Kampen, Inge Christensen, John Mogensen, Annette Larsen
  • Publication number: 20060111366
    Abstract: The use of substituted amides for modulating the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11?HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
    Type: Application
    Filed: October 11, 2005
    Publication date: May 25, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Andersen, Gita Camilla Kampen, Inge Christensen, John Mogensen, Annette Larsen, John Kilburn
  • Publication number: 20060106008
    Abstract: The use of fused 1,2,4-triazoles for modulating the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments has been described. The present compounds are modulators and more specifically inhibitors of the activity of 11?HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
    Type: Application
    Filed: October 11, 2005
    Publication date: May 18, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Andersen, Gita Camilla Kampen, Inge Christensen, John Mogensen, Annette Larsen
  • Publication number: 20060100235
    Abstract: The use of substituted 1,2,4-triazoles for modulating the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of substituted 1,2,4-triazoles, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments has been described. The present compounds are modulators and more specifically inhibitors of the activity of 11?HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
    Type: Application
    Filed: October 7, 2005
    Publication date: May 11, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Andersen, Gita, Camilla Kampen, Inge Christensen, John Mogensen, Annette Larsen